Nu Skin Enterprises Stock Price, News & Analysis (NYSE:NUS)

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NUS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View NUS analyst ratings or view top-rated stocks.

4 brokerages have issued 1 year target prices for Nu Skin Enterprises' shares. Their NUS share price targets range from $23.00 to $39.00. On average, they anticipate the company's stock price to reach $29.50 in the next year. This suggests a possible upside of 67.5% from the stock's current price.
View analysts price targets for NUS or view top-rated stocks among Wall Street analysts.

Nu Skin Enterprises' stock was trading at $42.16 at the beginning of the year. Since then, NUS shares have decreased by 58.2% and is now trading at $17.61.
View the best growth stocks for 2023 here.

Nu Skin Enterprises saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 2,300,000 shares, an increase of 28.5% from the October 15th total of 1,790,000 shares. Based on an average daily trading volume, of 571,300 shares, the days-to-cover ratio is currently 4.0 days. Currently, 4.7% of the shares of the company are short sold.
View Nu Skin Enterprises' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 21st 2024.
View our NUS earnings forecast.

Nu Skin Enterprises, Inc. (NYSE:NUS) announced its earnings results on Wednesday, November, 1st. The company reported $0.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.64 by $0.08. The company earned $498.80 million during the quarter, compared to the consensus estimate of $520.09 million. Nu Skin Enterprises had a net margin of 2.92% and a trailing twelve-month return on equity of 13.44%. The company's quarterly revenue was down 7.3% on a year-over-year basis. During the same period last year, the business posted $0.47 EPS.

Nu Skin Enterprises announced a quarterly dividend on Wednesday, November 1st. Investors of record on Friday, November 24th will be paid a dividend of $0.39 per share on Wednesday, December 6th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 8.86%. The ex-dividend date of this dividend is Wednesday, November 22nd.
Read our dividend analysis for NUS.

Nu Skin Enterprises (NYSE:NUS) pays an annual dividend of $1.56 per share and currently has a dividend yield of 8.88%. NUS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 23 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 132.20%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, NUS will have a dividend payout ratio of 65.82% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NUS.

ETFs with the largest weight of Nu Skin Enterprises (NYSE:NUS) stock in their portfolio include Invesco S&P SmallCap Consumer Staples ETF (PSCC), Invesco High Yield Equity Dividend Achievers ETF (PEY), Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD), Global X Health & Wellness ETF (BFIT), AdvisorShares Dorsey Wright Short ETF (DWSH),

Nu Skin Enterprises updated its FY23 earnings guidance on Wednesday, November, 1st. The company provided earnings per share guidance of $1.62-1.77 for the period, compared to the consensus EPS estimate of $2.36. The company issued revenue guidance of $1.92-1.96 billion, compared to the consensus revenue estimate of $2.05 billion.

72 employees have rated Nu Skin Enterprises Chief Executive Officer Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among the company's employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife (HLF), Mastercard (MA) and Netflix (NFLX).

Nu Skin Enterprises' stock is owned by many different institutional and retail investors. Top institutional shareholders include Invesco Ltd. (3.43%), Morgan Stanley (2.23%), Charles Schwab Investment Management Inc. (1.97%), Bank of New York Mellon Corp (1.54%), Northern Trust Corp (1.12%) and Victory Capital Management Inc. (0.92%). Insiders that own company stock include Andrew D Lipman, D Matthew Dorny, Edwina D Woodbury, Emma S Battle, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Laura Nathanson, Mark H Lawrence, Ritch N Wood, Ryan S Napierski, Steven Keith Hatchett and Steven Lund.
View institutional ownership trends.

Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.